| Particulars |
|
|
|
| Company Name
| ERIS Lifesciences Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
13.86 |
B.V. (₹) |
230.50 |
| Sales(₹ Cr.) |
1,704.03 |
NP (₹ Cr.) |
76.04 |
| NP Var% |
-74.00 |
Div% |
735.00 |
| CPS(₹) |
18.60 |
EPS (₹) |
5.50 |
| Traded Value(₹ Lakhs) |
25.30 |
52 Week High |
1,910.00 |
| 52 Week Low |
1,238.00 |
Price BSE |
1,337.00 |
| Price NSE |
1,336.00 |
Market Capital (₹ Cr.) |
18,531.30 |
| P/C Ratio |
71.90 |
P/E Ratio |
243.60 |
| Price Vs.BV |
5.80 |
|
| Latest Quarter |
| Year End |
202512 |
Sales (₹ Cr.) |
306.78 |
| NP(₹ Cr.) |
16.96 |
NP Var % |
853.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
1,526.13 |
| OPM |
28.47 |
NP |
116.31 |
| NP Var% |
243.62 |
EPS |
21.43 |
| PE |
62.41 |
|
|